DE69001454D1 - Aerosol-zusammensetzung fuer bilderzeugungs-diagnostik und therapie von krebs- und infektionsherden. - Google Patents

Aerosol-zusammensetzung fuer bilderzeugungs-diagnostik und therapie von krebs- und infektionsherden.

Info

Publication number
DE69001454D1
DE69001454D1 DE9090400628T DE69001454T DE69001454D1 DE 69001454 D1 DE69001454 D1 DE 69001454D1 DE 9090400628 T DE9090400628 T DE 9090400628T DE 69001454 T DE69001454 T DE 69001454T DE 69001454 D1 DE69001454 D1 DE 69001454D1
Authority
DE
Germany
Prior art keywords
compound
aerosol composition
cancer
therapy
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090400628T
Other languages
English (en)
Other versions
DE69001454T2 (de
Inventor
D Hinterland Lucien Dussourd
Pape Alain Le
Gerard Normier
Anne-Marie Pinel
Jacques Durand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE69001454D1 publication Critical patent/DE69001454D1/de
Publication of DE69001454T2 publication Critical patent/DE69001454T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Atmospheric Sciences (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE9090400628T 1989-03-08 1990-03-08 Aerosol-zusammensetzung fuer bilderzeugungs-diagnostik und therapie von krebs- und infektionsherden. Expired - Fee Related DE69001454T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898903034A FR2644059B1 (fr) 1989-03-08 1989-03-08 Compositions aerosols destinees a l'imagerie, au diagnostic et a la therapie ciblee de foyers inflammatoires et tumoraux

Publications (2)

Publication Number Publication Date
DE69001454D1 true DE69001454D1 (de) 1993-06-03
DE69001454T2 DE69001454T2 (de) 1993-08-26

Family

ID=9379492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090400628T Expired - Fee Related DE69001454T2 (de) 1989-03-08 1990-03-08 Aerosol-zusammensetzung fuer bilderzeugungs-diagnostik und therapie von krebs- und infektionsherden.

Country Status (10)

Country Link
US (1) US5362474A (de)
EP (1) EP0387154B1 (de)
JP (1) JPH03236332A (de)
AT (1) ATE88643T1 (de)
AU (1) AU626645B2 (de)
CA (1) CA2011772A1 (de)
DE (1) DE69001454T2 (de)
DK (1) DK0387154T3 (de)
ES (1) ES2054282T3 (de)
FR (1) FR2644059B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196609T1 (de) * 1993-07-28 2000-10-15 Diatide Inc Radiomarkierte glukane
US5406950A (en) * 1993-12-23 1995-04-18 Mallinckrodt Medical, Inc. Inhalable contrast agent
DE19529921C2 (de) * 1995-08-01 1997-09-25 Schering Ag Verwendung von MRT-Kontrastmitteln zur Ventilations-Bildgebung der Lunge
CA2215152A1 (en) * 1996-01-12 1997-07-17 Redcell Canada, Inc. Cellular and serum protein anchors for diagnostic imaging
GB9710604D0 (en) * 1997-05-22 1997-07-16 Nycomed Imaging As Contrast media

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
US3885197A (en) * 1974-02-01 1975-05-20 Lear Siegler Inc Light dimmer
FR2546756B1 (fr) * 1983-06-03 1985-11-29 Centre Nat Rech Scient Nouveaux derives immunostimulants, leur preparation et leur application comme medicament
ATE59966T1 (de) * 1983-09-26 1991-02-15 Ehrenfeld Udo Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
FR2570081B1 (fr) * 1984-09-10 1987-01-09 Pf Medicament Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation
FR2598434B1 (fr) * 1986-05-12 1988-09-16 Pf Medicament Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
FR2614306B1 (fr) * 1987-04-22 1989-07-28 Pf Medicament Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
FR2644059A1 (fr) 1990-09-14
US5362474A (en) 1994-11-08
FR2644059B1 (fr) 1994-03-04
ES2054282T3 (es) 1994-08-01
DE69001454T2 (de) 1993-08-26
AU5111490A (en) 1990-09-13
ATE88643T1 (de) 1993-05-15
CA2011772A1 (fr) 1990-09-08
AU626645B2 (en) 1992-08-06
EP0387154A1 (de) 1990-09-12
DK0387154T3 (da) 1993-05-24
JPH03236332A (ja) 1991-10-22
EP0387154B1 (de) 1993-04-28

Similar Documents

Publication Publication Date Title
MY107655A (en) Derivatives of benzofuran,benzothiophene,indole and indolizine,process for their preparation as well as the compositions containing them
MY124122A (en) Heterocyclic derivatives
ES2091323T3 (es) Medios de contraste.
DE59403338D1 (de) Oleophob modifizierte mikroporöse Polymere
MEP23008A (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
IL123776A0 (en) Novel derivatives of cyclodepsipeptide PF 1022
EA200100516A1 (ru) Производные 3,3-биарилпиперидина и 2,2-биарилморфолина
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
NO303783B1 (no) Substituerte aminofosfonatderivater og farmas°ytiske preparater derav
ATE109661T1 (de) Stimulanz für die kontraktionsbewegung des verdauungstraktes.
DE69001454D1 (de) Aerosol-zusammensetzung fuer bilderzeugungs-diagnostik und therapie von krebs- und infektionsherden.
FI882359A (fi) Cykliska antikoagulationspeptider. pi path slues6208 s880524 mlues6205 m881102
FI882358A (fi) Cykliska antikoagulationspeptider.
FR2575466B1 (fr) Nouveaux complexes de silicium hexacoordines, leur procede de preparation et leur application
ZA893346B (en) Anticoagulant peptide alcohols
PT73950A (fr) Procede de preparation de composes de dichloredietilaminopheni-lalanine d'action antitumureuse
DK471979A (da) Estere af 1,1,2-triphenylalkenderivater
ATE247955T1 (de) Selenophen-antitumormittel
SE8504657D0 (sv) Nya 5-fluor-2'-deoxiuridinderivat och slater derav, forfarande for deras framstellning och antitumormedel innehallande dessa
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
DK473286A (da) Konjugater af vinblastin og derivater deraf, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
IT1199652B (it) Composti ad attivita'antiiperlipidemica,loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee